UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2007 Commission File Number 1-14840 AMDOCS LIMITED Suite 5, Tower Hill House Le Bordage St. Peter Port, Island of Guernsey, GY1 3QT Channel Islands Amdocs, Inc. 1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. FORM 20-F X FORM 40-F ----- ----- Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ----- Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ----- Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to rule 12g3-2(b) under the Securities Exchange Act of 1934. YES NO X ----- -----
On July 18, 2007, Amdocs Limited ("Amdocs") issued a press release announcing financial results for the quarter ended March 31, 2007. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K. On July 18, 2007, Amdocs issued a press release announcing the appointment of Tamar Rapaport-Dagin as Chief Financial Officer of Amdocs Management Limited effective November 15, 2007. A copy of the press release is furnished as Exhibit 99.2 to this Report of Foreign Private Issuer on Form 6-K. The information in this Form 6-K (including Exhibit 99.1 and Exhibit 99.2) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMDOCS LIMITED /s/ Thomas G. O'Brien ---------------------------------------- Thomas G. O'Brien Treasurer and Secretary Authorized U.S. Representative Date: July 18, 2007
EXHIBIT INDEX EXHIBIT NO. DESCRIPTION - ----------- ------------------------------------------------- 99.1 Amdocs Limited Press Release dated July 18, 2007. 99.2 Amdocs Limited Press Release dated July 18, 2007.
Exhibit 99.1 AMDOCS LIMITED REPORTS RECORD REVENUE AND STRONG EARNINGS PRESS RELEASE (AMDOCS LOGO) AMDOCS REPORTS 10% GROWTH IN QUARTERLY DILUTED NON-GAAP EARNINGS PER SHARE TO $0.54; DILUTED GAAP EARNINGS PER SHARE OF $0.40 Key highlights: - Third quarter revenue increased 14% to $712 million - 10% increase in third quarter diluted non-GAAP EPS, excluding acquisition-related costs and equity-based compensation expense, net of related tax effects, to $0.54, exceeding guidance of $0.50-$0.52 - Diluted GAAP EPS of $0.40 for the quarter - Free cash flow of $87 million for the quarter - Fourth quarter fiscal 2007 guidance: Expected revenue of approximately $725-$735 million and diluted non-GAAP EPS of $0.52 - $0.54, excluding acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.40-$0.43 ST. LOUIS, MO - JULY 18, 2007 - Amdocs Limited (NYSE: DOX) today reported that for the quarter ended June 30, 2007, revenue was $712.1 million, an increase of 13.7% from last year's third quarter. Net income on a non-GAAP basis was $120.6 million, or $0.54 per diluted share (excluding acquisition-related costs, which include amortization of purchased intangible assets and excluding equity-based compensation expense, net of related tax effects, of $32.4 million), compared to non-GAAP net income of $106.2 million, or $0.49 per diluted share, in the third quarter of fiscal 2006 (excluding acquisition-related costs, which include amortization of purchased intangible assets and the write-off of in-process research and development and excluding equity-based compensation expense, net of related tax effects, of $20.6 million). The Company's GAAP net income was $88.2 million, or $0.40 per diluted share, compared to GAAP net income of $85.6 million, or $0.39 per diluted share, in the third quarter of fiscal 2006. Free cash flow for the quarter was $87.1 million, comprised of cash flow from operations of $126.5 million less $39.4 million in net capital expenditures and other.
"One of Amdocs' key differentiators is that our customers - the leading service providers in the world - view us as a strategic partner, and that translates into long-term relationships and continued new business opportunities with those customers. In fact, while we enjoyed new wins, much of the growth in revenue and earnings this quarter was driven by existing business," said Dov Baharav, chief executive officer of Amdocs Management Limited. "As service providers continue to transform themselves, Amdocs remains the partner of choice to deliver complex projects. During the quarter we met a number of key delivery milestones for our customers, which will lead to expanded business opportunities in the future." Baharav continued, "Amdocs is the only company to comprehensively address service providers' needs for customer experience systems innovation, offering the market-defining software portfolio combined with services that extend from strategy to execution. We combine relentless innovation with an unmatched foundation of business process best practices. We enjoy a unique competitive advantage steeped in industry expertise and unmatched experience working with the market leaders. We have sound reason to be excited about the opportunities for Amdocs and the growth of our company in the years to come." Amdocs new business included a variety of wins across geographies and lines of business. These wins include a transformation project to extend into OSS for a customer that is currently using Amdocs BSS systems. In the broadband cable and satellite market, the Company continued to convert subscribers onto an Amdocs system. The Company had other wins supporting next generation projects around the world and wins in the emerging markets. FINANCIAL OUTLOOK Amdocs expects that revenue for the fourth quarter of fiscal 2007 will be approximately $725-$735 million. Diluted earnings per share on a non-GAAP basis for the fourth quarter are expected to be $0.52-$0.54, excluding acquisition-related costs and approximately $0.05-$0.06 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.40-$0.43. Amdocs will host a conference call on July 18, 2007 at 5 p.m. Eastern Time to discuss the Company's third quarter results. The call will be carried live on the Internet via www.InvestorCalendar.com and the Amdocs website, www.amdocs.com.
NON-GAAP FINANCIAL MEASURES This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items: - amortization of purchased intangible assets; - in-process research and development write-off and other; - restructuring charges; - equity-based compensation expense; and - tax effects related to the above. These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs' results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs' results of operations in conjunction with the corresponding GAAP measures. Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business. For its internal budgeting process and in monitoring the results of the business, Amdocs' management uses financial statements that do not include amortization of purchased intangible assets, in-process research and development write-off and other, restructuring charges, equity-based compensation expense, and related tax effects. Amdocs' management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP
measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses. Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below. ABOUT AMDOCS Amdocs is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and the intentional customer experience(TM) - at every point of service. Amdocs provides solutions that deliver customer experience excellence, combining the software, service and expertise to help our customers execute their strategies and achieve service, operational and financial excellence. A global company with revenue of $2.48 billion in fiscal 2006, Amdocs has over 16,000 employees and serves customers in more than 50 countries around the world. For more information, visit Amdocs at www.amdocs.com. This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business
markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2006 and in our quarterly Form 6-K furnished on February 6 and May 11, 2007. CONTACT: Thomas G. O'Brien Treasurer and Vice President of Investor Relations Amdocs Limited 314-212-8328 E-mail: dox_info@amdocs.com
AMDOCS LIMITED CONSOLIDATED STATEMENTS OF INCOME (IN THOUSANDS, EXCEPT PER SHARE DATA) THREE MONTHS ENDED NINE MONTHS ENDED JUNE 30, JUNE 30, ------------------- ----------------------- 2007 2006 2007 2006 -------- -------- ---------- ---------- Revenue: License $ 43,821 $ 23,220 $ 113,091 $ 85,172 Service 668,270 603,228 1,996,393 1,729,433 -------- -------- ---------- ---------- 712,091 626,448 2,109,484 1,814,605 Operating expenses: Cost of license 960 995 3,045 2,973 Cost of service 448,795 402,626 1,330,776 1,165,010 Research and development 56,727 46,455 174,929 131,392 Selling, general and administrative 94,445 74,940 274,895 227,289 Amortization of purchased intangible assets 19,175 8,547 55,785 23,588 Restructuring charges, in-process research and development and other (1) -- 8,415 6,761 8,415 -------- -------- ---------- ---------- 620,102 541,978 1,846,191 1,558,667 -------- -------- ---------- ---------- Operating income 91,989 84,470 263,293 255,938 Interest income and other, net 14,290 14,938 36,928 33,659 -------- -------- ---------- ---------- Income before income taxes 106,279 99,408 300,221 289,597 Income taxes 18,098 13,823 31,527 46,916 -------- -------- ---------- ---------- Net income $ 88,181 $ 85,585 $ 268,694 $ 242,681 ======== ======== ========== ========== Basic earnings per share $ 0.42 $ 0.42 $ 1.30 $ 1.20 ======== ======== ========== ========== Diluted earnings per share (2) $ 0.40 $ 0.39 $ 1.22 $ 1.13 ======== ======== ========== ========== Basic weighted average number of shares outstanding 208,262 204,404 207,332 202,474 ======== ======== ========== ========== Diluted weighted average number of shares outstanding 223,775 220,109 222,997 217,633 ======== ======== ========== ========== (1) Restructuring charges, in-process research and development and other for the nine months ended June 30, 2007 include the following: restructuring charges of $6,011, in-process research and development of $2,666 offset by other acquisition related income of $1,916. Restructuring charges, in-process research and development and other for the three and nine months ended June 30, 2006 include in-process research and development of $8,415. (2) To reflect the impact of assumed conversion of the convertible notes, $985 and $2,955, representing interest expense and amortization of issuance costs, were added back to net income for the three and nine months ended June 30, 2007, respectively, and $985 and $2,964 were added back to net income for the three and nine months ended June 30, 2006, respectively, for the purpose of computing diluted earnings per share.
AMDOCS LIMITED SELECTED FINANCIAL METRICS (IN THOUSANDS, EXCEPT PER SHARE DATA) THREE MONTHS ENDED NINE MONTHS ENDED JUNE 30, JUNE 30, ------------------- ----------------------- 2007 2006 2007 2006 -------- -------- ---------- ---------- Revenue $712,091 $626,448 $2,109,484 $1,814,605 Non-GAAP operating income 123,843 112,380 365,809 319,889 Non-GAAP net income 120,576 106,169 353,163 291,678 Non-GAAP diluted earnings per share (1) $ 0.54 $ 0.49 $ 1.60 $ 1.35 Diluted weighted average number of shares outstanding 223,775 220,109 222,997 217,633 (1) To reflect the impact of assumed conversion of the convertible notes, $985 and $2,955, representing interest expense and amortization of issuance costs, were added back to net income for the three and nine months ended June 30, 2007, respectively, and $985 and $2,964 were added back to net income for the three and nine months ended June 30, 2006, respectively, for the purpose of computing diluted earnings per share.
AMDOCS LIMITED RECONCILIATION OF SELECTED FINANCIAL METRICS FROM GAAP TO NON-GAAP (IN THOUSANDS) THREE MONTHS ENDED JUNE 30, 2007 ---------------------------------------------------------- RECONCILIATION ITEMS ----------------------------------------------- AMORTIZATION OF PURCHASED EQUITY BASED INTANGIBLE COMPENSATION TAX GAAP ASSETS EXPENSE EFFECT NON-GAAP -------- ------------ ------------ ------ -------- Operating expenses: Cost of license $ 960 $ -- $ -- $ -- $ 960 Cost of service 448,795 -- (6,587) -- 442,208 Research and development 56,727 -- (1,734) -- 54,993 Selling, general and administrative 94,445 -- (4,358) -- 90,087 Amortization of purchased intangible assets 19,175 (19,175) -- -- -- -------- -------- -------- ----- -------- Total operating expenses 620,102 (19,175) (12,679) -- 588,248 -------- -------- -------- ----- -------- Operating income 91,989 19,175 12,679 -- 123,843 -------- -------- -------- ----- -------- Income taxes 18,098 -- -- (541) 17,557 -------- -------- -------- ----- -------- Net income $ 88,181 $ 19,175 $ 12,679 $ 541 $120,576 -------- -------- -------- ----- -------- THREE MONTHS ENDED JUNE 30, 2006 ---------------------------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------------------------ AMORTIZATION OF PURCHASED IN-PROCESS EQUITY BASED INTANGIBLE RESEARCH AND COMPENSATION TAX GAAP ASSETS DEVELOPMENT EXPENSE EFFECT NON-GAAP -------- ------------ ------------- ------------ -------- -------- Operating expenses: Cost of license $ 995 $ -- $ -- $ -- $ -- $ 995 Cost of service 402,626 -- -- (4,165) -- 398,461 Research and development 46,455 -- -- (1,232) -- 45,223 Selling, general and administrative 74,940 -- -- (5,551) -- 69,389 Amortization of purchased intangible assets 8,547 (8,547) -- -- -- -- Restructuring charges, in-process research and development and other 8,415 -- (8,415) -- -- -- -------- ------- ------- -------- ------- -------- Total operating expenses 541,978 (8,547) (8,415) (10,948) -- 514,068 -------- ------- ------- -------- ------- -------- Operating income 84,470 8,547 8,415 10,948 -- 112,380 -------- ------- ------- -------- ------- -------- Income taxes 13,823 -- -- -- 7,326 21,149 -------- ------- ------- -------- ------- -------- Net income $ 85,585 $ 8,547 $ 8,415 $ 10,948 $(7,326) $106,169 -------- ------- ------- -------- ------- --------
AMDOCS LIMITED RECONCILIATION OF SELECTED FINANCIAL METRICS FROM GAAP TO NON-GAAP (IN THOUSANDS) NINE MONTHS ENDED JUNE 30, 2007 --------------------------------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------------------------- RESTRUCTURING CHARGES, AMORTIZATION IN-PROCESS EQUITY OF PURCHASED RESEARCH AND BASED INTANGIBLE DEVELOPMENT COMPENSATION TAX GAAP ASSETS AND OTHER EXPENSE EFFECT NON-GAAP ---------- ------------ ------------- ------------- --------- ---------- Operating expenses: Cost of license $ 3,045 $ -- $ -- $ -- $ -- $ 3,045 Cost of service 1,330,776 -- -- (18,914) -- 1,311,862 Research and development 174,929 -- -- (5,099) -- 169,830 Selling, general and administrative 274,895 -- -- (15,957) -- 258,938 Amortization of purchased intangible assets 55,785 (55,785) -- -- -- -- Restructuring charges, in-process research and development and other 6,761 -- (6,761) -- -- -- ---------- -------- ------- -------- -------- ---------- Total operating expenses 1,846,191 (55,785) (6,761) (39,970) -- 1,743,675 ---------- -------- ------- -------- -------- ---------- Operating income 263,293 55,785 6,761 39,970 -- 365,809 ---------- -------- ------- -------- -------- ---------- Income taxes 31,527 -- -- -- 18,047 49,574 ---------- -------- ------- -------- -------- ---------- Net income $ 268,694 $ 55,785 $ 6,761 $ 39,970 $(18,047) $ 353,163 ---------- -------- ------- -------- -------- ----------
AMDOCS LIMITED RECONCILIATION OF SELECTED FINANCIAL METRICS FROM GAAP TO NON-GAAP (IN THOUSANDS) NINE MONTHS ENDED JUNE 30, 2006 --------------------------------------------------------------------------------- RECONCILIATION ITEMS ------------------------------------------------------- AMORTIZATION EQUITY OF PURCHASED IN-PROCESS BASED INTANGIBLE RESEARCH AND COMPENSATION TAX GAAP ASSETS DEVELOPMENT EXPENSE EFFECT NON-GAAP ---------- ------------ ------------- ------------- --------- ---------- Operating expenses: Cost of license $ 2,973 $ -- $ -- $ -- $ -- $ 2,973 Cost of service 1,165,010 -- -- (12,237) -- 1,152,773 Research and development 131,392 -- -- (3,041) -- 128,351 Selling, general and administrative 227,289 -- -- (16,670) -- 210,619 Amortization of purchased intangible assets 23,588 (23,588) -- -- -- -- Restructuring charges, in-process research and development and other 8,415 -- (8,415) -- -- -- ---------- -------- ------- -------- -------- ---------- Total operating expenses 1,558,667 (23,588) (8,415) (31,948) -- 1,494,716 ---------- -------- ------- -------- -------- ---------- Operating income 255,938 23,588 8,415 31,948 -- 319,889 ---------- -------- ------- -------- -------- ---------- Income taxes 46,916 -- -- -- 14,954 61,870 ---------- -------- ------- -------- -------- ---------- Net income $ 242,681 $ 23,588 $ 8,415 $ 31,948 $(14,954) $ 291,678 ---------- -------- ------- -------- -------- ----------
AMDOCS LIMITED CONDENSED CONSOLIDATED BALANCE SHEETS (IN THOUSANDS) AS OF ----------------------- JUNE 30, SEPTEMBER 2007 30, 2006 ---------- ---------- ASSETS Current assets Cash, cash equivalents and short-term interest-bearing investments $1,151,649 $ 979,381 Accounts receivable, net, including unbilled of $54,243 and $54,117 respectively 480,433 425,805 Deferred income taxes and taxes receivable 130,876 136,044 Prepaid expenses and other current assets 93,991 97,476 ---------- ---------- Total current assets 1,856,949 1,638,706 Equipment, vehicles and leasehold improvements, net 258,272 220,290 Goodwill and other intangible assets, net 1,804,077 1,809,322 Other noncurrent assets 364,502 294,510 ---------- ---------- Total assets $4,283,800 $3,962,828 ========== ========== LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities Accounts payable and accruals $ 548,126 $ 597,107 Short-term portion of capital lease obligations and other financing arrangements 2,029 1,963 Deferred revenue 243,917 253,376 Deferred income taxes and taxes payable 209,635 179,241 ---------- ---------- Total current liabilities 1,003,707 1,031,687 0.50% Convertible notes 450,000 450,000 Noncurrent liabilities and other 315,216 326,976 Shareholders' equity 2,514,877 2,154,165 ---------- ---------- Total liabilities and shareholders' equity $4,283,800 $3,962,828 ========== ========== # # #
[amdocs logo] Press Release Amdocs Announces Appointment of Tamar Rapaport-Dagim as Chief Financial Officer Effective November 15, 2007 Ron Moskovitz Will Continue To Serve as Chief Financial Officer During the Transition Period St. Louis, MO - July 18, 2007 - The Amdocs Limited (NYSE: DOX) board of directors today announced that effective November 15, 2007, Tamar Rapaport-Dagim will become the chief financial officer of Amdocs Management Limited. Rapaport-Dagim will succeed Ron Moskovitz, who will be resigning to manage an international private business. Moskovitz will continue to serve as CFO until November 15, 2007 in order to assist in the transition. "Ron has been a key member of the Amdocs management team and has contributed greatly to our success over the past nine years," said Dov Baharav, chief executive officer of Amdocs Management Limited. "We thank him for his excellent service for the Company and wish him well in his new role. With Ron's assistance, we expect a smooth transition for Tamar into her new position." Rapaport-Dagim joined Amdocs in 2004 as Vice President of Finance reporting to Moskovitz. Prior to joining Amdocs, Rapaport-Dagim was the CFO of Emblaze, a provider of multimedia solutions over wireless and IP networks and traded on the London Stock Exchange. She has also been the controller of Teledata Networks and has held various finance management positions in public accounting. Rapaport-Dagim holds BA and MBA degrees from Tel Aviv University and is a certified public accountant. "It is with mixed emotions that I leave Amdocs but I look forward to this next challenge in my career," said Moskovitz. "I take comfort in knowing that the Company is in great shape and in good hands with Tamar". About Amdocs Amdocs is the market leader in customer experience systems innovation, enabling world-leading service providers to deliver an integrated, innovative and the intentional customer experienceTM - at every point of service. Amdocs provides solutions that deliver customer experience excellence, combining the software, service and expertise to help our customers execute their strategies and achieve service, operational & financial excellence. A global company with revenue of $2.48 billion in fiscal 2006, Amdocs has over 16,000 employees and serves customers in more than 50 countries around the world. For more information, visit Amdocs at www.amdocs.com. This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company's filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2006 and in our quarterly Form 6-K furnished on February 6 and May 11, 2007. Contact: Thomas G. O'Brien Treasurer and Vice President of Investor Relations Amdocs Limited 314-212-8328 E-mail: dox_info@amdocs.com